Abstract
Obstructive sleep apnea is highly prevalent in patients with erectile dysfunction, and the mechanisms implicated in this association appear to be very complex. The causation and the dose-response manner of the relationship between severity of obstructive sleep apnea and known risk factors predisposing to the development of erectile dysfunction has been suggested in multiple studies. Line of evidence linked OSA to obesity, hypertension, type 2 diabetes, and cerebrovascular and coronary diseases, all of which are tightly related to the aggravated erectile function. However, a direct negative influence of unhandled sleep-disordered breathing on ED should not be disregarded. Since these data are further enhanced by evidence showing advantageous effects of CPAP therapy on erectile performance in patients with OSA, the elimination of sleep apnea may constitute an important strategy in the management of these patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Guilleminault C, Eldridge FL, Tilkian A, Simmons FB, Dement WC (1977) Sleep apnea syndrome due to upper airway obstruction: a review of 25 cases. Arch Intern Med 137:296–300
American Academy of Sleep Medicine (2005) International classification of sleep disorders, 2nd edn. Diagnostic and coding manual. Westchester, IL: American Academy of Sleep Medicine
Young T, Palta M, Dempsey J et al (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328:1230–1235
Logan AG, Perlikowski SM, Mente A et al (2001) High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 2001(19):2271–2277
Grote L, Hedner J, Grunstein R et al (2000) Therapy with nCPAP: incomplete elimination of Sleep Related Breathing Disorder. Eur Respir J 16:921–927
Newman AB, Nieto FJ, Guidry U, Lind BK, Redline S, Pickering TG, Quan SF, Sleep Heart Health Study Research Group (2001) Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol 154:50–59
Feldman HA, Johannes CB, Derby CA, Kleinman KP, Mohr BA, Araujo AB, McKinlay JB (2000) Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev Med 30:328–338
Hammoud AO, Gibson M, Peterson CM, Hamilton BD, Carrell DT (2006) Obesity and male reproductive potential. J Androl 27:619–626
Wolk R, Shamsuzzaman AS, Somers VK (2003) Obesity, sleep apnea, and hypertension. Hypertension 42:1067–1074
Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K (2004) Bariatric surgery: a systematic review and meta-analysis. JAMA 292:1724–1737
Baud MO, Magistretti PJ, Petit JM (2013) Sustained sleep fragmentation affects brain temperature, food intake and glucose tolerance in mice. J Sleep Res 22:3–12
Calvin AD, Carter RE, Adachi T, Macedo PG, Albuquerque FN, van der Walt C, Bukartyk J, Davison DE, Levine JA, Somers VK (2013) Effects of experimental sleep restriction on caloric intake and activity energy expenditure. Chest 144:79–86
Phillips BG, Kato M, Narkiewicz K et al (2000) Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol 279:H234–H237
Patel SR, Palmer LJ, Larkin EK et al (2004) Relationship between obstructive sleep apnea and diurnal leptin rhythms. Sleep 27:206–210
Sánchez-de-la-Torre M, Mediano O, Barceló A, Piérola J, de la Peña M, Esquinas C, Miro A, Durán-Cantolla J, Agustí AG, Capote F, Marin JM, Montserrat JM, García-Río F, Barbé F (2012) The influence of obesity and obstructive sleep apnea on metabolic hormones. Sleep Breath 16:649–656
Dobrosielski DA, Patil SP (2013) Weight loss and obstructive sleep apnea: what lies AHEAD? SLEEP 36:627–629
Esposito KG, Giugliano F, Di Palo C, Giugliano G, Marfella R, D’Andrea F, D’Armiento M, Giugliano D (2004) Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 291:2978–2984
Despres JP, Lemieux I (2006) Abdominal obesity and metabolic syndrome. Nature 444:881–887
Hermans MP, Ahn SA, Rousseau MF (2009) Erectile dysfunction, microangiopathy and UKPDS risk in type 2 diabetes. Diabetes Metab 35:484–489
Resnick HE, Redline S, Shahar E, Gilpin A, Newman A, Walter R, Ewy GA, Howard BV, Punjabi NM, Sleep Heart Health Study (2003) Diabetes and sleep disturbances: findings from the Sleep Heart Health Study. Diabetes Care 26:702–709
Foster GD, Sanders MH, Millman R, Zammit G, Borradaile KE, Newman AB, Wadden TA, Kelley D, Wing RR, Sunyer FX, Darcey V, Kuna ST, Sleep AHEAD Research Group (2009) Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes Care 32:1017–1019
Pillai A, Warren G, Gunathilake W, Idris I (2011) Effects of sleep apnea severity on glycemic control in patients with type 2 diabetes prior to continuous positive airway pressure treatment. Diabetes Technol Ther 13:945–949
Dawson A, Abel SL, Loving RT, Dailey G, Shadan FF, Cronin JW, Kripke DF, Kline LE (2008) CPAP therapy of obstructive sleep apnea in type 2 diabetics improves glycemic control during sleep. J Clin Sleep Med 4:538–542
Babu AR, Herdegen J, Fogelfeld L, Shott S, Mazzone T (2005) Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med 165:447–452
Lavie P, Herer P, Hoffstein V (2000) Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 320:479–482
Peppard PE, Young T, Palta M et al (2000) Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342:1378–1784
Nieto FJ, Young TB, Lind BK et al (2000) Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 283:1829–1836
Calhoun DA (2010) Obstructive sleep apnea and hypertension. Curr Hypertens Rep 12:189–195
Logan AG, Perlikowski SM, Mente A et al (2001) High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 19:2271–2277
Lloberes P, Lozano L, Sampol G et al (2010) Obstructive sleep apnoea and 24-h blood pressure in patients with resistant hypertension. J Sleep Res 19:597–602
Pedrosa RP, Drager LF, Gonzaga CC et al (2011) Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension 58:811–817
Brooks D, Horner RL, Kozar LF et al (1997) Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest 99:106–109
Fava C, Dorigoni S, Dalle Vedove F, Danese E, Montagnana M, Guidi GC, Narkiewicz K, Minuz P (2013) Effect of continuous positive airway pressure (CPAP) on blood pressure in patients with obstructive sleep apnea/hypopnea. A systematic review and meta-analysis (2014). Chest 145:762–771
Wilcox I, Grunstein RR, Hedner JA et al (1993) Effect of nasal continuous positive airway pressure during sleep on 24-hour blood pressure in obstructive sleep apnea. Sleep 16:539–544
Faccenda JF, Mackay TW, Boon NA et al (2001) Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea–hypopnea syndrome. Am J Respir Crit Care Med 163:344–348
Pepperell JC, Ramdassingh-Dow S, Crosthwaite N et al (2002) Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 359:204–210
Shahar E, Whitney CW, Redline S et al (2001) Sleep-disordered breathing and cardiovascular disease. Cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163:19–25
Peker Y, Kraiczi H, Hedner J et al (1999) An independent association between obstructive sleep apnoea and coronary artery disease. Eur Respir J 13:179–184
Peker Y, Hedner J, Kraiczi H et al (2000) Respiratory disturbance index – an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 162:81–86
Guilleminault C, Connolly SJ, Winkle RA (1983) Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 52:490–494
Gami AS, Pressman G, Caples SM et al (2004) Association of atrial fibrillation and obstructive sleep apnea. Circulation 110:364–367
Mehra R, Benjamin EJ, Sahar E et al (2006) Association of nocturnal arrhythmias with sleep-disordered breathing. The Sleep Heart Health Study. Am J Respir Crit Care Med 173:910–916
Kanagala R, Murali NS, Friedman PA et al (2003) Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 107:2589–2594
Szymański FM, Puchalski B, Filipiak KJ (2013) Obstructive sleep apnea, atrial fibrillation, and erectile dysfunction: are they only coexisting conditions or a new clinical syndrome? The concept of the OSAFED syndrome. Pol Arch Med Wewn 123:701–707
Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V (2005) Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 353:2034–2041
Martinez-Garcia MA, Galiano-Blancart R, Roman-Sanchez P et al (2005) Continuous positive airway pressure treatment in sleep apnea prevents new vascular events after ischemic stroke. Chest 128:2123–2129
Johnson CB, Beanlands RS, Yoshinaga K et al (2008) Acute and chronic effects of continuous positive airway pressure therapy on left ventricular systolic and diastolic function in patients with obstructive sleep apnea and congestive heart failure. Can J Cardiol 24:697–704
Wittert G (2014) The relationship between sleep disorders and testosterone in men. Asian J Androl 16:262–265
Hoekema A, Stel AL, Stegenga B, van der Hoeven JH, Wijkstra PJ, van Driel MF, de Bont LG (2007) Sexual function and obstructive sleep apnea-hypopnea: a randomized clinical trial evaluating the effects of oral-appliance and continuous positive airway pressure therapy. J Sex Med 4:1153–1162
Bratel T, Wennlund A, Carlström K (1999) Pituitary reactivity, androgens and catecholamines in obstructive sleep apnoea. Effects of continuous positive airway pressure treatment (CPAP). Respir Med 93:1–7
Luboshitzky R, Lavie L, Shen-Orr Z, Lavie P (2003) Pituitary-gonadal function in men with obstructive sleep apnea. The effect of continuous positive airways pressure treatment. Neuro Endocrinol Lett 24:463–467
Grunstein RR, Handelsman DJ, Lawrence SJ, Blackwell C, Caterson ID, Sullivan CE (1989) Neuroendocrine dysfunction in sleep apnea: reversal by continuous positive airways pressure therapy. J Clin Endocrinol Metab 68:352–358
Knapp A, Myhill PC, Davis WA, Peters KE, Hillman D, Hamilton EJ, Lim EM, Davis TM (2014) Effect of continuous positive airway pressure therapy on sexual function and serum testosterone in males with type 2 diabetes and obstructive sleep apnoea. Clin Endocrinol (Oxf) 81:254–258
Budweiser S, Enderlein S, Jörres RA, Hitzl AP, Wieland WF, Pfeifer M, Arzt M (2009) Sleep apnea is an independent correlate of erectile and sexual dysfunction. J Sex Med 6:3147–3157
Taskin U, Yigit O, Acioglu E, Aricigil M, Toktas G, Guzelhan Y (2010) Erectile dysfunction in severe sleep apnea patients and response to CPAP. Int J Impot Res 22:134–139
Fanfulla F, Malaguti S, Montagna T, Salvini S, Bruschi C, Crotti P, Casale R, Rampulla C (2000) Erectile dysfunction in men with obstructive sleep apnea: an early sign of nerve involvement. Sleep 23:775–781
Reishtein JL, Maislin G, Weaver TE, Multisite Study group (2010) Outcome of CPAP treatment on intimate and sexual relationships in men with obstructive sleep apnea. J Clin Sleep Med 6:221–226
Margel D, Cohen M, Livne PM, Pillar G (2004) Severe, but not mild, obstructive sleep apnea syndrome is associated with erectile dysfunction. Urology 63:545–549
Gonçalves MA, Guilleminault C, Ramos E, Palha A, Paiva T (2005) Erectile dysfunction, obstructive sleep apnea syndrome and nasal CPAP treatment. Sleep Med 6:333–339
Carlson JT, Rangemark C, Hedner JA (1996) Attenuated endothelium-dependent vascular relaxation in patients with sleep apnoea. J Hypertens 14:577–584
Kraiczi H, Caidahl K, Samuelsson A et al (2001) Impairment of vascular endothelial function and left ventricular filling. Association with the severity of apnea-induced hypoxemia during sleep. Chest 119:1085–1091
Kato M, Roberts-Thomson P, Phillips BG et al (2000) Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 102:2607–2610
Bayram NA, Ciftci B, Keles T et al (2009) Endothelial function in normotensive men with obstructive sleep apnea before and 6 months after CPAP treatment. Sleep 32:1257–1263
Somers VK, Dyken ME, Clary MP, Abboud FM (1995) Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96:1897–1904
Phillips BG, Narkiewicz K, Pesek CA et al (1999) Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens 17:61–66
Jordan W, Reinbacher A, Cohrs S et al (2005) Obstructive sleep apnea: Plasma endothelin-1 precursor but not endothelin-1 levels are elevated and decline with nasal continuous positive airway pressure. Peptides 26:1654–1660
Gjørup PH, Sadauskiene L, Wessels J et al (2007) Abnormally increased endothelin-1 in plasma during the night in obstructive sleep apnea: relation to blood pressure and severity of disease. Am J Hypertens 20:44–52
Moller DS, Lind P, Strunge B et al (2003) Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea. Am J Hypertens 16:274–280
Calhoun DA, Nishizaka MK, Zaman MA et al (2004) Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea. Chest 125:112–117
Shamsuzzaman AS, Winnicki M, Lanfranchi P et al (2002) Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105:2462–2464
Kokturk O, Ciftci TU, Mollarecep E et al (2005) Elevated C-reactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome. Int Heart J 46:801–809
Yokoe T, Minoguchi K, Matsuo H et al (2003) Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107:1129–1134
Budweiser S, Luigart R, Jörres RA, Kollert F, Kleemann Y, Wieland WF, Pfeifer M, Arzt M (2013) Long-term changes of sexual function in men with obstructive sleep apnea after initiation of continuous positive airway pressure. J Sex Med 10:524–531
Margel D, Tal R, Livne PM, Pillar G (2005) Predictors of erectile function improvement in obstructive sleep apnea patients with long-term CPAP treatment. Int J Impot Res 17:186–190
Treatment compliance with continuous positive airway pressure device among adults with obstructive sleep apnea (OSA): how many adhere to treatment? (2013) Harefuah 152:140–144. Abstract
Bostrom KB, Hedner J, Melander O et al (2007) Interaction between the angiotensin-converting enzyme gene insertion/deletion polymorphism and obstructive sleep apnoea as a mechanism for hypertension. J Hypertens 25:779–783
Younes M, Ostrowski M, Thompson W et al (2001) Chemical control stability in patients with obstructive sleep apnea. Am J Respir Crit Care Med 163:1181–1190
Xie A, Bedekar A, Skatrud JB et al (2011) The heterogeneity of obstructive sleep apnea (predominant obstructive vs pure obstructive apnea). Sleep 34:745–750
Kapur VK, Resnick HE, Gottlieb DJ (2008) Sleep disordered breathing and hypertension: does self-reported sleepiness modify the association? Sleep 31:1127–1132
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Wolf, J., Narkiewicz, K. (2015). Erectile Dysfunction and Sleep Apnea. In: Viigimaa, M., Vlachopoulos, C., Doumas, M. (eds) Erectile Dysfunction in Hypertension and Cardiovascular Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-08272-1_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-08272-1_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-08271-4
Online ISBN: 978-3-319-08272-1
eBook Packages: MedicineMedicine (R0)